BU-NOT-SET

CONTACT US
Product Quality in the Advanced Therapies Manufacturing
  • Biologics
men in lab
White paper
Navigating ATMP fill and finish complexities
  • Biologics
lab
Insight
The power of analytics and AI in the era of continuous RNA manufacturing
  • Biologics
people in a lab
Insight
Reimagining the RNA manufacturing space: An interview with ReciBioPharm’s leaders
  • Biologics
person in lab
Insight
Unlocking the potential of mRNA: Inside ReciBioPharm's Watertown site
  • Biologics
mRNA
Insight
Industry 5.0 in action: AI-driven continuous manufacturing for RNA therapeutics
  • Biologics
vaccine in bottles
Insight
Choosing the optimal container format for sterile drug products
  • Drug product
  • Manufacturing
Containers for sterile drug products
Insight
FDA inspection success at Recipharm’s site in Bengaluru, India
  • Manufacturing
Two people looking at a printed document
Insight
Lyophilisation Services
  • Drug product
  • Manufacturing
bottles
Fact sheet
Insight
  • Drug product
Dosage form development trends and technologies
Insight
  • Drug product
  • Manufacturing
Vaccine Development and Manufacturing
Insight
  • Analytical chemistry
Identifying impurities using advanced analytics
Insight
  • Industry trends
Recipharm on the impact of COVID-19 on API supply
Insight
  • Drug product
The role of excipient selection in the development of orally disintegrating tablets
Case study
  • Analytical chemistry
Solving analytical method challenges to advance animal antibiotic
Insight
  • Industry trends
The outlook for a year of change
Insight
  • Drug product
Can oral solid dose keep its place as the leading dosage form?
Insight
  • Drug substance
Relocating API supply to avoid over-reliance